Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Go back to Bayer and Atara Biotherapeutics (ATRA) Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
(NASDAQ: ATRA) Delayed: 10.99 +0.38 (3.58%)
Previous Close $10.61    52 Week High $40.80 
Open $10.43    52 Week Low $12.45 
Day High $10.99    P/E N/A 
Day Low $10.43    EPS $0.00 
Volume 15,776